SMTL ID : 2bxq.1

Human serum albumin complexed with myristate, phenylbutazone and indomethacin

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

6 x MYR: MYRISTIC ACID(Non-covalent)

MYR.1: 8 residues within 4Å: Chain A: R.117, M.123, Y.138, L.139, A.158, Y.161, F.165 Ligands: IMN.9 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:Y.138, A:Y.138, A:Y.138, A:L.139, A:A.158, A:Y.161, A:Y.161, A:Y.161, A:F.165 Salt bridges: A:R.117, A:R.186 MYR.2: 11 residues within 4Å: Chain A: L.14, F.19, V.23, L.66, Y.150, L.251, A.254, R.257, L.283, L.284, S.287 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.14, A:F.19, A:V.23, A:L.66, A:L.251, A:A.254, A:L.283, A:L.284 Hydrogen bonds: A:Y.150, A:S.287, A:S.287 Salt bridges: A:R.257 MYR.3: 8 residues within 4Å: Chain A: S.342, V.344, R.348, P.384, I.388, G.434, L.453, R.485 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:I.388 Hydrogen bonds: A:S.342, A:S.342 Salt bridges: A:R.348, A:R.485 MYR.4: 6 residues within 4Å: Chain A: L.387, R.410, Y.411, R.485, F.488, S.489 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:Y.411, A:Y.411 Hydrogen bonds: A:Y.411, A:Y.411 Salt bridges: A:R.410, A:K.414 MYR.5: 13 residues within 4Å: Chain A: Y.401, N.405, F.502, F.507, K.525, A.528, L.529, V.547, M.548, F.551, A.552, S.579, Q.580 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:F.502, A:K.525, A:A.528, A:V.547, A:F.551, A:Q.580 Hydrogen bonds: A:Y.401 Salt bridges: A:K.525 MYR.6: 8 residues within 4Å: Chain A: R.209, A.213, D.324, L.327, G.328, A.350, K.351, S.480 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:A.213, A:L.327, A:A.350 Hydrogen bonds: A:S.480, A:S.480 Water bridges: A:R.209 Salt bridges: A:K.351

2 x IMN: INDOMETHACIN(Non-covalent)

IMN.7: 11 residues within 4Å: Chain A: K.199, S.202, A.210, F.211, W.214, A.215, R.218, L.219, L.238, L.481 Ligands: P1Z.8 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:F.211, A:F.211, A:W.214, A:W.214, A:L.481 Water bridges: A:R.218 Salt bridges: A:R.218 pi-Stacking: A:W.214 IMN.9: 12 residues within 4Å: Chain A: R.114, L.115, I.142, R.145, H.146, F.149, F.157, Y.161, R.186, G.189, K.190 Ligands: MYR.1 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.115, A:I.142, A:F.149, A:R.186, A:K.190, A:K.190 Hydrogen bonds: A:L.115, A:L.115 Salt bridges: A:R.145

1 x P1Z: 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE(Non-covalent)

P1Z.8: 14 residues within 4Å: Chain A: K.199, L.219, R.222, F.223, L.238, H.242, R.257, L.260, A.261, I.264, S.287, I.290, A.291 Ligands: IMN.7 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:K.199, A:L.219, A:L.219, A:F.223, A:L.260, A:I.264, A:I.290, A:A.291 Hydrogen bonds: A:R.222, A:R.257 Water bridges: A:R.222 pi-Cation interactions: A:R.257

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ghuman, J. et al., Structural Basis of the Drug-Binding Specificity of Human Serum Albumin. J.Mol.Biol. (2005)

Release Date

2005-09-22

Peptides

SERUM ALBUMIN: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

SERUM ALBUMIN

Related Entries With Identical Sequence